Home Postdoc Abroad Postdoctoral Research Fellow in Brain Tumor Biology & Cancer Immunology at MUSC,...

Postdoctoral Research Fellow in Brain Tumor Biology & Cancer Immunology at MUSC, USA

Post-Doctoral Fellowship Position at USA, Ozbolat Laboratory at Penn State

The Song Laboratory in the Department of Neuroscience and the Hollings Cancer Center at the Medical University of South Carolina (MUSC) is currently inviting applications for a motivated and talented Postdoctoral Research Fellow. The fellow will spearhead innovative research exploring the molecular mechanisms driving glioma progression, therapeutic resistance, and tumor-immune dynamics.

Job Overview and Quick Details

Designation:Postdoctoral Research Fellow
Research Group:Song Laboratory (PI: Dr. Xiao Song)
Department/Center:Department of Neuroscience / Hollings Cancer Center
Institution:Medical University of South Carolina (MUSC)
Location:Charleston, South Carolina, United States
Research Focus:Brain Tumor Biology, RNA Splicing, Glioma, Cancer Immunology, Functional Genomics
Remuneration:Competitive salary based on NIH postdoctoral stipend guidelines plus university benefits
Application Deadline:Open until filled (Applications reviewed on a rolling basis)

Summary

The Song Laboratory integrates cutting-edge functional genomics, transcriptomics, molecular/cellular biology, human iPSC models, and preclinical glioma models to decipher crucial mechanisms in neuro-oncology. Supported by substantial institutional start-up packages, NIH/NINDS R21 awards, and a DoD Career Development Award, this role provides an outstanding setting for fellows aiming to build high-impact scientific discoveries and transition into independent academic or industrial careers.

Research Area & Project Directions

The fellow will have the opportunity to lead or contribute to one or more of the following key research thrusts based on their technical background and research interests:

  • Functional Discovery of Alternative Splicing Dependencies in Glioma: Implementing exon-centric CRISPR knockout/activation screening approaches combined with RNA-seq and preclinical models to uncover novel splicing vulnerabilities governing glioma growth and drug resistance.
  • Alternative Splicing and Sphingolipid Metabolism: Exploring how regulated alternative splicing of metabolic genes alters lipid networks, driving glioma progression, metabolic rewiring, and therapeutic susceptibility.
  • Targeting RNA Splicing Regulators (e.g., PTBP1): Characterizing the role of critical splicing factors in glioma progression and intrinsic tumor immune responses, evaluating therapeutic targets via patient-derived glioma models and in vivo mouse systems.
  • iPSC-Derived Microglia and Cellular Immunotherapy: Investigating phagocytosis and immune recognition of glioma cells by human iPSC-derived microglia, developing genetically engineered microglia as a platform for brain tumor immunotherapy.

Eligibility and Qualifications

Required Qualifications:

  • Ph.D. or equivalent doctoral degree in Cancer Biology, Molecular Biology, Immunology, Neuroscience, Stem Cell Biology, Biochemistry, or a closely related biomedical field.
  • Demonstrated track record of scientific productivity and research achievement (e.g., peer-reviewed publications).
  • Strong hands-on experience and foundational knowledge in molecular and cell biology.
  • Demonstrated capacity to independently design, troubleshoot, and execute laboratory experiments.
  • Strong written and verbal communication skills in English, with an aptitude for collaborative, multidisciplinary teamwork.

Preferred Qualifications (Experience in any of the following):

  • RNA biology, pre-mRNA alternative splicing, or transcriptome analysis.
  • CRISPR/Cas9 functional genomic screening or gene editing techniques.
  • Tumor immunology, immune-oncology assays, or tumor microenvironment characterization.
  • Human iPSC culture, directed differentiation, or macrophage/microglia biology.
  • Multicolor flow cytometry, confocal microscopy, or preclinical animal handling (rodent brain tumor models).
  • Bioinformatics pipelines, bulk/single-cell RNA-sequencing (scRNA-seq), or high-throughput data analysis.

Note: Applicants are not required to possess expertise across all preferred areas; researchers with strong competence in any of these domains are encouraged to apply.

Work Environment & Benefits

MUSC is South Carolina’s premier academic medical center, home to Hollings Cancer Center (the state’s only NCI-designated cancer center). Postdoctoral fellows benefit from high-end shared core resources, interdisciplinary translational collaborations, and comprehensive career development resources including grant-writing mentorship and conference presentation opportunities. The position offers an NIH-scale stipend along with university health and retirement benefits.

Last Date for Apply

Applications will be reviewed on a rolling basis until the position is filled. Early application is strongly advised.

How to Apply

Interested candidates should prepare and compile the following application documents:

  1. A detailed Curriculum Vitae (CV) including an up-to-date list of publications and presentations.
  2. A Cover Letter summarizing prior research accomplishments, scientific motivations, and specific research directions of interest within the Song Lab.
  3. Contact details (names, affiliations, and email addresses) for 2–3 professional references.

Submit your complete application package via email directly to the Principal Investigator:

Contact Person: Dr. Xiao Song, Ph.D.
Email: songx@musc.edu
Subject Line: Postdoctoral Application – [Your Full Name]

Official Link

For additional details regarding the laboratory’s ongoing projects, visit the official announcement page: Song Lab Postdoctoral Opening.

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here